BioSpace News Archive

Business

Viela Bio Appoints Mitchell Chan as Chief Financial Officer

Viela Bio announced the appointment of Mitchell Chan as Chief Financial Officer, effective July 1.

July 1, 2019
·
2 min read
Drug Development

Alnylam Submits Marketing Authorization Application to the European Medicines Agency for Givosiran for the Treatment of Acute Hepatic Porphyria

Patients Receiving Givosiran in Pivotal Phase 3 ENVISION Study had a 74 Percent Mean Reduction in Annualized Rate of Composite Porphyria Attacks Compared to Placebo

July 1, 2019
·
10 min read
BioForest

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

Cardiac Dimensions® announced the Carillon Mitral Contour System® has been implanted in 1,000 patients in the United States, Europe, Australia, Turkey and the Middle East.

July 1, 2019
·
4 min read
Deals

Century Therapeutics Launches With USD 250M Financing for Induced Pluripotent Stem Cell (iPSC) Allogeneic Cell Therapy Platform - July 1, 2019

Created by Versant Ventures and partnered with Fujifilm to develop iPSC-derived adaptive and innate immune effector cell therapies

July 1, 2019
·
7 min read
Top 5 Vendors in the Global Neuroendocrine Tumors Therapeutics Market 2019-2023 | Technavio

The global neuroendocrine tumors therapeutics market is highly concentrated. Because of the high investment required for drug development and commercialization, vendors are focusing on entering into partnerships with other companies.

July 1, 2019
·
4 min read
Drug Development

Biohaven Enrolls First Patient in Phase 2 Clinical Trial of Rimegepant, Oral CGRP Receptor Antagonist, for Treatment Refractory Trigeminal Neuralgia

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today announced that the first patient has been enrolled in a Phase 2 clinical tria

July 1, 2019
·
5 min read
Business

Lifestyle Delivery Systems Inc. Announces an Exclusive Agreement to Amalgamate Lifestyle Delivery Systems Inc. with TransCanna Holdings Inc.

This transaction, if completed, would allow for the operational foundation created by LDS to be expanded into the TCAN northern California facility in a significant way.

July 1, 2019
·
5 min read
Bio NC

DisposeRx Medication Disposal Solution Now Included with Government Contract, Furthering Commitment to Veterans and Military

DisposeRx, a drug disposal company committed to eradicating the misuse of leftover medications in the home medicine cabinet, today announced that the U.S. Department of Veterans Affairs (VA) will offer its drug disposal solution for at-home use by veterans.

July 1, 2019
·
3 min read
Business

Velan Urges Stockholders To Follow ISS’ Recommendation By Voting “Against” Progenics Pharmaceuticals Directors Peter Crowley And Michael Kishbauch

Velan Capital, L.P. (together with the other participants in its solicitation, “Velan” or “we”), today issued a statement reminding stockholders that now is the time to demand accountability at Progenics and to follow the recommendation of Institutional Shareholder Services Inc.

July 1, 2019
·
6 min read
Business

PTC Therapeutics Announces Strategic Gene Therapy Licensing Agreement with Odylia Therapeutics

Collaboration expands PTC’s Gene Therapy portfolio to rare ophthalmic diseases

July 1, 2019
·
4 min read